IRIS
GIALLONGO, CESARINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 5.646
EU - Europa 4.257
AS - Asia 2.850
AF - Africa 504
SA - Sud America 450
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 2
Totale 13.715
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 5.492
IT - Italia 1.815
RU - Federazione Russa 1.297
SG - Singapore 1.268
CN - Cina 829
BR - Brasile 369
CI - Costa d'Avorio 331
IE - Irlanda 292
VN - Vietnam 277
FR - Francia 152
UA - Ucraina 142
KR - Corea 139
DE - Germania 115
CA - Canada 100
GB - Regno Unito 100
IN - India 75
FI - Finlandia 63
NG - Nigeria 52
SE - Svezia 52
JP - Giappone 51
SN - Senegal 51
PL - Polonia 47
NL - Olanda 41
MX - Messico 39
HK - Hong Kong 36
BD - Bangladesh 31
AR - Argentina 30
CZ - Repubblica Ceca 27
ES - Italia 25
IQ - Iraq 23
ZA - Sudafrica 19
CH - Svizzera 18
BE - Belgio 16
BJ - Benin 16
EC - Ecuador 16
TR - Turchia 15
LB - Libano 11
AE - Emirati Arabi Uniti 9
CL - Cile 9
IL - Israele 9
MA - Marocco 9
UZ - Uzbekistan 9
GR - Grecia 8
ID - Indonesia 8
KE - Kenya 8
LT - Lituania 8
NP - Nepal 7
PK - Pakistan 7
PY - Paraguay 7
AT - Austria 6
JO - Giordania 6
TN - Tunisia 6
AU - Australia 5
IR - Iran 5
SA - Arabia Saudita 5
VE - Venezuela 5
AL - Albania 4
CO - Colombia 4
EG - Egitto 4
ET - Etiopia 4
HR - Croazia 4
NO - Norvegia 4
PH - Filippine 4
RO - Romania 4
SI - Slovenia 4
BO - Bolivia 3
KZ - Kazakistan 3
NI - Nicaragua 3
OM - Oman 3
RS - Serbia 3
SY - Repubblica araba siriana 3
TH - Thailandia 3
UY - Uruguay 3
AZ - Azerbaigian 2
CR - Costa Rica 2
DZ - Algeria 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
KG - Kirghizistan 2
KH - Cambogia 2
LV - Lettonia 2
MY - Malesia 2
PE - Perù 2
PS - Palestinian Territory 2
PT - Portogallo 2
SR - Suriname 2
SV - El Salvador 2
AM - Armenia 1
BF - Burkina Faso 1
BG - Bulgaria 1
CY - Cipro 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
EE - Estonia 1
EU - Europa 1
GE - Georgia 1
HU - Ungheria 1
KW - Kuwait 1
MK - Macedonia 1
Totale 13.710
Salva come PNG Salva come JPEG
Città #
Dallas 1.293
Singapore 863
Santa Clara 664
Moscow 654
Catania 479
Chandler 453
San Jose 390
Ashburn 338
Abidjan 330
Chicago 296
Dublin 286
Hefei 227
Jacksonville 156
Beijing 149
Los Angeles 146
Seoul 139
Boardman 123
Lauterbourg 93
Civitanova Marche 91
Florence 86
Houston 82
Rome 82
Ho Chi Minh City 76
New York 75
Council Bluffs 74
Cambridge 68
Lawrence 68
Andover 64
Milan 63
Palermo 60
Dakar 51
Hanoi 50
São Paulo 50
Buffalo 49
Toronto 48
Dong Ket 44
Warsaw 44
Munich 43
Nanjing 42
Des Moines 36
Messina 34
Tokyo 34
Hong Kong 33
Abuja 28
Bari 28
Orem 28
Bronte 26
Misterbianco 26
Bremen 25
Helsinki 24
Montreal 24
Wilmington 24
Amsterdam 23
Lagos 23
Lappeenranta 23
Paris 22
Chennai 21
London 20
The Dalles 20
Boston 19
Brno 19
Brooklyn 19
Saint Petersburg 19
San Mateo 19
Stockholm 19
Falls Church 18
Nanchang 18
Poplar 18
Denver 17
Shenyang 17
Washington 17
Atlanta 16
Cotonou 16
Turin 16
Turku 16
Columbus 15
Brussels 14
Dearborn 14
Fukuoka 14
Johannesburg 14
Manchester 14
Mexico City 14
Mumbai 14
Naples 14
Seattle 14
Acireale 12
Augusta 12
Hebei 12
Kochi 12
Ottawa 12
Guangzhou 11
San Francisco 11
Changsha 10
Haiphong 10
Mascalucia 10
Aci Catena 9
Ankara 9
Belpasso 9
Caltagirone 9
Charlotte 9
Totale 9.492
Salva come PNG Salva come JPEG
Nome #
Activity-Dependent Neuroprotective Protein (ADNP)-Derived Peptide (NAP) Counteracts UV-B Radiation-Induced ROS Formation in Corneal Epithelium 278
Biological properties of Cakile maritima Scop. (Brassicaceae) extracts 240
Antimicrobial and anti-proliferative effects of skin mucus derived from dasyatis pastinaca (Linnaeus, 1758) 225
α-Lipoic Acid Reduces Iron-induced Toxicity and Oxidative Stress in a Model of Iron Overload 224
CXCL12/CXCR4 axis supports mitochondrial trafficking in tumor myeloma microenvironment 216
Biological properties of itraconazole-SLN 212
Anaplastic thyroid cancer cells reduce CD71 levels to increase iron overload tolerance 208
Inhibition of TLR4 signaling affects mitochondrial fitness and overcomes bortezomib resistance in myeloma plasma cells 205
Clobetasol promotes neuromuscular plasticity in mice after motoneuronal loss via sonic hedgehog signaling, immunomodulation and metabolic rebalancing 196
Antiproliferative and Antiangiogenic Effects of Punica granatum Juice (PGJ) in Multiple Myeloma (MM) 194
Clobetasol modulates adult neural stem cell growth via canonical hedgehog pathway activation 188
A cytoprotective role for the heme oxygenase-1/CO pathway during neural differentiation of human mesenchymal stem cells 185
In-vitro NET-osis induced by COVID-19 sera is associated to severe clinical course in not vaccinated patients and immune-dysregulation in breakthrough infection 185
Glioblastoma mesenchymal subtype enhances antioxidant defence to reduce susceptibility to ferroptosis 184
ACVR1: A Novel Therapeutic Target to Treat Anemia in Myelofibrosis 181
Focus on Osteosclerotic Progression in Primary Myelofibrosis 181
Lactate accumulation promotes immunosuppression and fibrotic transformation of bone marrow microenvironment in myelofibrosis 178
Heme Oxygenase Inhibition Sensitizes Neuroblastoma Cells to Carfilzomib 177
Ixazomib improves bone remodeling and counteracts sonic hedgehog signaling inhibition mediated by myeloma cells 177
Heme oxygenase-1 nuclear translocation regulates bortezomib-induced cytotoxicity and mediates genomic instability in myeloma cells. 176
Biological properties of itraconazole-SLNs 170
Chitinase domain containing 1 increase is associated with low survival rate and M0 macrophages infiltrates in colorectal cancer patients 169
Purine metabolism rewiring improves glioblastoma susceptibility to temozolomide treatment 161
Hedgehog signaling pathways in multiple myeloma 161
Clinical outcome of SARS-CoV-2 infections occurring in multiple myeloma patients after vaccination and prophylaxis with tixagevimab/cilgavimab 159
High-density neutrophils in MGUS and multiple myeloma are dysfunctional and immune-suppressive due to increased STAT3 downstream signaling 159
Plasticity of High-Density Neutrophils in Multiple Myeloma is Associated with Increased Autophagy via STAT3 158
Lactate Induces the Expressions of MCT1 and HCAR1 to Promote Tumor Growth and Progression in Glioblastoma 157
Mesenchymal stromal cells in tumor microenvironment remodeling of BCR-ABL negative myeloproliferative diseases 156
Lactate trafficking inhibition restores sensitivity to proteasome inhibitors and orchestrates immuno-microenvironment in multiple myeloma 156
Bortezomib modulates CHIT1 and YKL40 in monocyte-derived osteoclast and in myeloma cells. 154
Role of 17β-Estradiol on Cell Proliferation and Mitochondrial Fitness in Glioblastoma Cells 154
Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 152
Biochemical and clinical relevance of alpha lipoic acid: antioxidant and anti-inflammatory activity, molecular pathways and therapeutic potential 150
Bortezomib Inhibits Osteoclastogenesis and Bone Resorption Through Modulation of CHIT1 and YKL40 Expression 150
Targeted Metabolomics Highlights Dramatic Antioxidant Depletion, Increased Oxidative/Nitrosative Stress and Altered Purine and Pyrimidine Concentrations in Serum of Primary Myelofibrosis Patients 149
Mitochondrial Functions, Energy Metabolism and Protein Glycosylation are Interconnected Processes Mediating Resistance to Bortezomib in Multiple Myeloma Cells 149
Immune off-target effects of Brentuximab Vedotin in relapsed/refractory Hodgkin Lymphoma 148
Monocytic myeloid-derived suppressor cells as prognostic factor in chronic myeloid leukaemia patients treated with dasatinib 146
Lactate Rewrites the Metabolic Reprogramming of Uveal Melanoma Cells and Induces Quiescence Phenotype 143
Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models 142
PMN-MDSC and arginase are increased in myeloma and may contribute to resistance to therapy 141
BORTEZOMIB INHIBITS OSTEOCLASTOGENESIS AND MODULATE CHIT1 AND YKL40 EXPRESSION 140
Correction to: Neuroprotective Role of α-Lipoic Acid in Iron-Overload-Mediated Toxicity and Inflammation in In Vitro and In Vivo Models (Antioxidants, (2022), 11, 8, (1596), 10.3390/antiox11081596) 139
SPARC expression in CML is associated to imatinib treatment and to inhibition of leukemia cell proliferation 137
Bortezomib Could Reduce Cell Viability by Activation of Heme Oxygenase 1 in Multiple Myeloma Cells 137
TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma 137
Iron regulates myeloma cell/macrophage interaction and drives resistance to bortezomib 137
Immune Response and Breakthrough Infection Risk After SARS-CoV-2 Vaccines in Patients with Hemoglobinopathy: A Single Center Experience 135
Effect of lipoic acid on the biochemical mechanisms of resistance to bortezomib in SH-SY5Y neuroblastoma cells 135
Clinical impact of the immunome in lymphoid malignancies: the role of Myeloid-Derived Suppressor Cells 134
Ruxolitinib treatment in myelofibrosis and polycythemia vera causes suboptimal humoral immune response following standard and booster vaccination with BNT162b2 mRNA COVID-19 vaccine 132
CIRCULATING ARGINASE-1 IN SERUM IS A NOVEL BIO-MARKERIN HODGKIN LYMPHOMA 130
Correction: TLR4 signaling drives mesenchymal stromal cells commitment to promote tumor microenvironment transformation in multiple myeloma (Cell Death & Disease, (2019), 10, 10, (704), 10.1038/s41419-019-1959-5) 130
Pericytes in microvessels: From “mural” function to brain and retina regeneration 128
The Role of Epigenetics in Neuroinflammatory-Driven Diseases 127
Targeted metabolomic evaluation of peripheral blood mononucleated cells from patients with PMM2-CDG 126
Effects of second-generation tyrosine kinase inhibitors towards osteogenic differentiation of human mesenchymal cells of healthy donors 126
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint. 126
Concomitant and feasible treatment with dasatinib and the anti-EGFR antibody cetuximab plus radiotherapy in a CML patient with multiple squamous neoplasias 125
The Heme Oxygenase System in Hematological Malignancies 124
Engagement of Mesenchymal Stromal Cells in the Remodeling of the Bone Marrow Microenvironment in Hematological Cancers 123
Electronic nicotine delivery systems exhibit reduced bronchial epithelial cells toxicity compared to cigarette: the Replica Project 121
Nuclear translocation of Heme oxygenase-1 confers resistance to imatinib in chronic myeloid leukemia cells 120
Correction to: Lactate modulates microglia polarization via IGFBP6 expression and remodels tumor microenvironment in glioblastoma 119
Prediction of Survival and Prognosis Migration from Gold-Standard Scores in Myelofibrosis Patients Treated with Ruxolitinib Applying the RR6 Prognostic Model in a Monocentric Real-Life Setting 119
MacroH2A1.1 as a crossroad between epigenetics, inflammation and metabolism of mesenchymal stromal cells in myelodysplastic syndromes 117
BRIT1/MCPH1 expression in chronic myeloid leukemia and its regulation of the G2/M checkpoint 117
Rebalancing Immune Interactions within the Brain-Spleen Axis Mitigates Neuroinflammation in an Aging Mouse Model of Alzheimer’s Disease 116
Myelofibrosis and Survival Prognostic Models: A Journey between Past and Future 112
Myeloid-derived suppressor cells in Chronic myeloid leukemia 112
Modulation of extracellular signal-related kinase, cyclin D1, glial fibrillary acidic protein, and vimentin expression in estradiol-pretreated astrocyte cultures treated with competence and progression growth factors 110
Proteomic analysis reveals autophagy as pro-survival pathway elicited by long-term exposure with 5-azacitidine in high-risk myelodysplasia 109
Mitochondrial Bioenergetics at the Onset of Drug Resistance in Hematological Malignancies: An Overview 108
IGFBP-6/sonic hedgehog/TLR4 signalling axis drives bone marrow fibrotic transformation in primary myelofibrosis 107
Neuroactive molecules and growth factors modulate cytoskeletal protein expression during astroglial cell proliferation and differentiation in culture 103
Mesenchymal Stem Cells (MSC) Regulate Activation of Granulocyte-Like Myeloid Derived Suppressor Cells (G-MDSC) in Chronic Myeloid Leukemia Patients 102
TLR4 Signaling and Heme Oxygenase-1/Carbon Monoxide Pathway Crosstalk Induces Resiliency of Myeloma Plasma Cells to Bortezomib Treatment 100
Effects of imatinib mesylate in osteoblastogenesis 98
Ixazomib inhibits osteoclastogenesis and promotes osteogenic differentiation in vitro 96
Immune responses to oligomeric α-synuclein in Parkinson’s disease peripheral blood mononuclear cells 95
Mesenchymal Stem Cells (MSC) from Patients with Multiple Myeloma Promote Myeloid Cells to Become Granulocytic-Myeloid-Derived Suppressor Cells (G-MDSC) with Immunosuppressive, Bone Resorption and Pro-Angiogenic Activity 89
MESENCHYMAL STEM CELLS FROM CML PATIENTS REGULATE MYELOID DERIVED SUPPRESSOR CELLS ACTIVATION 87
OVEREXPRESSION OF ARGINASE AND PROK-2 MAKES NEUTROPHILS OF MULTIPLE MYELOMA DYSFUNCTIONAL AND IMMUNOSUPPRESSIVE 87
MONOCYTIC MYELOID DERIVED SUPPRESSOR CELLS (M-MDSC) AS PROGNOSTIC FACTOR IN DASATINIB TREATED PATIENTS WITH CHRONIC MYELOID LEUKEMIA 87
Pituitary Adenylate Cyclase-Activating Polypeptide Protects Corneal Epithelial Cells against UV-B-Induced Apoptosis via ROS/JNK Pathway Inhibition 86
GRANULOCYTE-LIKE MYELOID DERIVED SUPPRESSOR CELLS ARE INCREASED IN MULTIPLE MYELOMA DUE TO IMMUNOLOGICAL DYSREGULATION OF MESENCHYMAL STEM CELLS 84
The Pleiotropic Effects of Fumarate: From Mitochondrial Respiration to Epigenetic Rewiring and DNA Repair Mechanisms 82
The prognostic value of the myeloid-mediated immunosuppression marker Arginase-1 in classic Hodgkin lymphoma. 78
Deficiency and haploinsufficiency of histone macroH2A1.1 in mice recapitulate hematopoietic defects of human myelodysplastic syndrome 78
IMPAIRED NEUTROPHIL FUNCTION IN PATIENTS WITH ACUTE LEUKEMIA 77
Immunoproteasome Genes Are Modulated in CD34+ JAK2V617F Mutated Cells from Primary Myelofibrosis Patients 77
Uveal melanoma cells elicit retinal pericyte phenotypical and biochemical changes in an in vitro model of coculture 77
Proteasome inhibitors as a possible therapy for SARS-CoV-2 76
Mesenchymal Stromal Cells (MSC) As Key Players in the Tumor Microenvironment Transformation from MGUS to Myeloma 76
LENALIDOMIDE TREATMENT IS ABLE TO RESTORE REGULATORY T CELLS IN MULTIPLE MYELOMA PATIENTS 73
Monocytic myeloid derived suppressor cells in hematological malignancies 73
Imatinib increases cytotoxicity of melphalan and their combination allows an efficient killing of chronic myeloid leukemia cells 72
Myeloid derived suppressor cells (MDSCs) are increased and exert immunosuppressive activity together with polymorphonuclear leukocytes (PMNs) in chronic myeloid leukemia patients 71
Granulocyte-like myeloid derived suppressor cells (G-MDSC) are increased in multiple myeloma and are driven by dysfunctional mesenchymal stem cells (MSC) 70
Totale 13.603
Salva come PNG Salva come JPEG
Categoria #
all - tutte 40.702
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 40.702
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021125 0 0 0 0 0 0 0 0 0 0 49 76
2021/2022653 41 77 10 4 116 26 101 49 51 31 18 129
2022/20231.368 96 112 40 144 111 188 19 237 267 44 71 39
2023/2024928 55 140 39 40 47 203 40 88 4 25 168 79
2024/20252.886 42 456 155 198 522 357 157 136 175 226 242 220
2025/20266.954 417 883 1.051 479 950 1.536 581 175 378 441 63 0
Totale 13.918